Table 1 Comparison of patients’ characteristics with multiple and solitary PSP.

From: Multiple pulmonary sclerosing pneumocytoma, based on a study of 36 cases worldwide

 

Multiple PSP

Single PSP

P value

n

%

n

%

Published time (n)

36

43

 

 Before 2000

3

8.33

   

 2000–2005

5

13.89

   

 2006–2010

3

8.33

   

 2011–2015

6

16.67

   

 2016–2020

19

52.78

   

Distribution area (n)

36

43

 

 Asia

32

88.89

38

100.00

 

 Other

4

11.11

   

Gender (n)

36

43

0.1974

 Male

6

16.67

12

27.91

 

 Female

30

83.33

31

72.09

 

Age (year) (n)

36

43

0.0035

 Mean ± SD

40.36 ± 18.12

51.28 ± 12.74

 

 Quartile

37 (25, 54.5)

52(43, 60)

 

 Range

16–73

24–74

 

Diagnosis (n)

34

43

 

 Percutaneous lung biopsy

6

17.65

   

 Intraoperative pathology

4

11.76

   

 Postoperative pathology

24

70.59

43

100.00

 

Tumour size (mm) (n)

28

43

0.1649

 Mean ± SD

43.54 ± 46.18

30.56 ± 17.62

 

 Quartile

27.5 (20, 50)

27(20, 36)

 

Extrapulmonary metastasis (n)

 Yes/no

3/33

0/43

 

Misdiagnosis (n)

10

27.78

0

  

 Pulmonary tuberculosis

4

11.11

   

 Lung metastases

4

11.11

   

 Others

2

5.56

   

Therapy (n)

34

43

 

 Sublobar resection

13

38.24

16

37.21

 

 Sublobar resection + lobectomy

2

5.88

   

 Lobectomy

8

23.53

27

62.79

 

 Pneumonectomy

6

17.65

   

 Observation

5

14.71

   
  1. PSP pulmonary sclerosing pneumocytoma.